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Summary
Objective: In this study, the human chondrosarcoma cell line SW1353 was investigated by gene expression analysis in order to validate it as
an in vitro model for primary human (adult articular) chondrocytes (PHCs).
Methods: PHCs and SW1353 cells were cultured as high density monolayer cultures with and without 1 ng/ml interleukin-1b (IL-1b). RNA was
isolated and assayed using a custom-made oligonucleotide microarray representing 312 chondrocyte-relevant genes. The expression levels
of selected genes were conﬁrmed by real-time polymerase chain reaction and the gene expression proﬁles of the two cell types, both with and
without IL-1b treatment, were compared.
Results: Overall, gene expression proﬁling showed only very limited similarities between SW1353 cells and PHCs at the transcriptional level.
Similarities were predominantly seen with respect to catabolic effects after IL-1b treatment. In both cell systems matrix metalloproteinase-1
(MMP-1), MMP-3 and MMP-13 were strongly induced by IL-1b, without signiﬁcant induction of MMP-2. IL-6 was also found to be up-regulated
by IL-1b in both cellular models. On the other hand, intercellular mediators such as leucemia inhibitory factor (LIF) and bone morphogenetic
protein-2 (BMP-2) were not induced by IL-1b in SW1353 cells, but signiﬁcantly up-regulated in PHCs. Bioinformatical analysis identiﬁed
nuclear factor kappa-B (NFkB) as a common transcriptional regulator of IL-1b induced genes in both SW1353 cells and PHCs, whereas other
transcription factors were only found to be relevant for individual cell systems.
Conclusion: Our data characterize SW1353 cells as a cell line with only a very limited potential to mimic PHCs, though SW1353 cells can be of
value to study the induction of protease expression within cells, a phenomenon also seen in chondrocytes.
ª 2005 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.





Investigations of primary human (adult articular) chondro-
cytes (PHCs) are limited by the lack of a sufﬁcient number
of chondrocytes from operative procedures and the fact that
after isolation, the biological and functional characteristics
of PHCs differ considerably between donors and prepara-
tions1,2. Proliferative activity of PHCs in vitro implicates
dedifferentiation, with loss of the typical chondrocytic cell
morphology, as well as a signiﬁcant change in the pattern of
gene expression3. Long-term investigations of physiological
characteristics of PHCs are hampered due to the rapid
phenotypic destabilization of these cells.
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a substitute for PHCs. In this situation, chondrosarcoma-
derived cell lines are a promising substitute for a chondro-
cytic experimental system, displaying sufﬁcient proliferative
activity and the ability to display a consistent response to
phenotype modulating stimuli. The following study investi-
gated the gene expression proﬁle of the chondrosarcoma-
derived cell line SW1353 using DNA microarray technology.
SW1353 cells have been used in many studies to look at
chondrocytic transcription factors (TFs) such as SOX94,5, to
test chondrosarcoma-targeted gene therapy6, and to study
protease expression and regulation in chondrocytic
cells7e10. The SW1353 expression proﬁles obtained in this
study were correlated with data from PHCs in order to
analyze the suitability of this chondrosarcoma-derived cell
line as a substitute of PHCs for experimental research.
Methods
CULTURING OF SW1353 CELLS AND STIMULATION WITH IL-1b
SW1353 cells were obtained from American Type Culture
Collection (ATCC) (no. HTB-94) and cultured in Dulbecco’s
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many) with 10% FCS (fetal bovine serum; Gibco BRL,
Germany) in humidiﬁed atmosphere 5% CO2 in air at 37(C.
Monolayer cells were washed in phosphate buffered saline
(PBS) three times and stimulated with 1 ng/ml interleukin-1b
(IL-1b) (Roche Diagnostics, Germany) in DMEM/F12 con-
taining 0.5% lactalbumin enzyme hydrolysate (Sigma,
Germany).
ISOLATION, CULTURING, AND STIMULATION OF PHCs
Macroscopically normal human knee articular cartilage
(from femoral condyles and tibial plateaus) was obtained
from six donors at autopsy, within 48 h of death (46 years
male, 52 years male, 64 years female, 64 years male, 66
years female, 79 years male). Cartilage pieces were ﬁnely
chopped and chondrocytes were enzymatically isolated
from the associated matrix: sliced cartilage pieces were ﬁrst
digested with 1 mg/ml pronase (Roche, Switzerland) in
DMEM/F12 with 10% FCS (Biochrom, Berlin, FRG) for
30 min prior to incubation with 1 mg/ml collagenase P
(Boehringer Mannheim, FRG) overnight in Hams-F12
(Gibco BRL, Germany) with 10% FCS. Cells were then
washed several times in Hams-F12 and counted and
checked for viability using trypan blue staining.
After isolation, chondrocytes were seeded at 2! 106
cells/well in 6-well tissue culture plates and maintained for
48 h in DMEM/F12 medium supplemented with 10% FCS,
50 mg/ml penicillin/streptomycin solution (Gibco BRL, Ger-
many) and 50 mg/ml ascorbate (Sigma, Germany).
Thereafter, (the non-passaged) chondrocytes were stim-
ulated with 1 ng/ml recombinant human IL-1b (Biomol,
Germany) in DMEM/F12 medium containing 10% FCS
(Biochrom, Berlin, FRG) or cultivated in medium containing
10% FCS alone for 3 days (except the enzyme-linked
immunoabsorbant assay (ELISA) experiments which were
performed using 0.1 ng/ml IL-1b). The medium was changed
everyday. At the end of the stimulation period the cells were
washed in sterile PBS, lysed in 350 ml lysis RLT buffer/106
cells (Qiagen GmbH, Germany) and stored at 80(C.
RNA ISOLATION AND QUALITY CONTROL
RNA isolation from isolated chondrocytes was performed
as described previously11. RNA was isolated from cultured
cells using the RNeasy mini-kit (Qiagen, Germany) (with an
on-column DNAse digestion step according to the manufac-
turer’s instructions). Brieﬂy, lysates of cells were passed
through a Qiashredder (Qiagen, Germany) and the eluted
lysatesmixed 1:1 with 70%ethanol. The lysates were applied
to a mini-column and after washing and DNAse I digestion,
the RNAs were eluted in 30e50 ml of RNAse-free water. The
quantity and quality of total RNA samples was checked by
agarose-gel-electrophoresis and using the Bioanalyzer RNA
6000 Nano assay (Agilent, Waldbronn, Germany).
cDNA SYNTHESIS
First strand cDNA was synthesized using 1 mg of total
RNA, 400 U M-MLV reverse transcriptase, RNase H minus
(Promega, Mannheim, FRG), 2 mM dNTPs (Roth, FRG)
and 200 ng random primers (Promega, Mannheim, FRG) in
a total volume of 40 ml.
TAQMAN PCR
TAQMAN polymerase chain reaction (PCR) was used to
detect mRNA expression levels of human anabolic (aggre-
can, Col2) and catabolic (MMP-1, -2, -3, -13, ADAMTS-4(a disintegrin and metalloproteinase with thrombospondin
motifs) gene products as well as important mediators (IL-1b,
IL-6, LIF) and TFs (SOX5/6/9). The primers (MWG Biotech,
Germany) and TAQMAN probes (Eurogentec, Belgium)
were designed using PRIMER EXPRESS software
(Perkin Elmer). In order to be able to obtain quantiﬁable
results for all genes, speciﬁc standard curves using
sequence-speciﬁc control probes were performed in parallel
to the analyses as described previously12. For the standard
curves 101, 102, 103, 104, 105, as well as 106 molecules per
assay were used (all in triplicate).
For the analyses of the different genes, a separate
master-mix was made up for each of the primer pairs and
contained a ﬁnal concentration of 200 mM NTPs, 600 nM
Roxbuffer and 100 nM TAQMAN probe. For all genes the
ﬁnal reaction mix contained [besides cDNA and 1 U
polymerase (Eurogentec, Belgium)] forward and reverse
primers, the corresponding probes, and MgCl2 at concen-
trations given in Table I. All experiments were performed in
triplicate.
CONSTRUCTION OF THE SENSICHIP CARTILAGE
MICROARRAY
The SensiChip technology (Qiagen, Zeptosens) is a two-
color microarray platform using the Planar Wave Guide
technology for microarray detection13, which increases
signal to noise ratios and thereby sensitivity of hybridization
experiments. The arrays were spotted in duplicates with
70-mer oligonucleotides representing the 3#-UTR of 312
housekeeping and human cartilage-relevant genes. Every
single gene was represented by one 70-mer oligonucleotide
(the list of genes is available online http://www.bio.iﬁ.
lmu.de/publications/SW1353). The gene-speciﬁc oligonu-
cleotide sequences were designed by Operon (Cologne,
Germany) using respective GenBank accession numbers
and proprietary algorithms.
SENSICHIP MICROARRAY EXPERIMENTS e TIME COURSE
STUDIES WITH IL-1b
The SW1353 time course study consisted of three
independent culture series of SW1353 monolayers treated
with 1 ng/ml IL-1b (Roche Diagnostics, Germany) in DMEM/
F12 (Gibco BRL, Germany) containing 0.5% lactalbumin
enzymatic hydrolysate (Sigma, Germany) or control medium
(DMEM/F12/0.5% lactalbumin enzymatic hydrolysate) for
30 min, 6 h, 16 h, 24 h and 48 h. From each of the 30
cultures RNA was isolated using the RNeasy Kit (Qiagen).
Total RNA (1 mg) from IL-1b-treated and control cultures was
reverse transcribed in the presence of Alexa-labeled or Cy5-
labeled dUTP nucleotides using the Omniscript Kit (Qiagen)
and generated cDNA was subsequently puriﬁed using the
QIAquick Kit (Qiagen).
Due to limited amounts of RNA starting material, 250 ng
total RNA from IL-1b-stimulated PHCs and unstimulated
controls from each time point (30 min, 6 h, 16 h, 24 h and
48 h) was ampliﬁed and thereby labeled with Cy3-UTP and
Cy5-UTP, respectively (Amersham Pharmacia), using the
MessageAmp aRNA Kit (Ambion). After cRNA clean-up
using the RNeasy kit (Qiagen), 5 mg of Cy3-labeled cRNA
from IL-1b-stimulated chondrocytes was mixed with 5 mg of
Cy5-labeled cRNA from the respective unstimulated con-
trol. cRNA was fragmented by incubation with 40 mM TRIS-
acetate, pH 8.1, 100 mM KOAc, 30 mM MgOAc for 15 min
at 95(C and desalted using a Microcon YM-10 concentrator
(Millipore).
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Sequences and concentrations of primers and probes as well as magnesium conditions for quantitative real-time PCR experiments
Accession no. Primer nM Probe (all 100 nM) Mg (mM)
GAPDH NM_002046 fw: GAAGGTGAAGGTCGGAGTC 50 CAAGCTTCCCGTTCTCAGCC 5.5
rv: GAAGATGGTGATGGGATTTC 900
Aggrecan NM_013227 fw: ACTTCCGCTGGTCAGATGGA 50 CCATGCAATTTGAGAACTGGCGCC 6
rv: TCTCGTGCCAGATCATCACC 50
COL2A1 NM_001844 fw: CAACACTGCCAACGTCCAGAT 50 ACCTTCCTACGCCTGCTGTCCACG 5.5
rv: CTGCTTCGTCCAGATAGGCAAT 300
MMP-1 NM_002421 fw: CTGTTCAGGGACAGAATGTGCT 300 ACGGATACCCCAAGGACATCTACAGCTCC 6.5
rv: TCGATATGCTTCACAGTTCTAGGG 900
MMP-2 NM_004530 fw: TCACTCCTGAGATCTGCAAACAG 300 TTGATGGCATCGCTCAGATCCGTG 6
rv: TCACAGTCCGCCAAATGAAC 900
MMP-3 NM_002422 fw: TTTTGGCCATCTCTTCCTTCA 900 AACTTCATATGCGGCATCCACGCC 4
rv: TGTGGATGCCTCTTGGGTATC 300
MMP-13 NM_002427 fw: TCCTCTTCTTGAGCTGGACTCATT 900 TCCTCAGACAAATCATCTTCATCACCACCAC 7
rv: CGCTCTGCAAACTGGAGGTC 50
ADAMTS-4 AF148213 fw: TGCCCGCTTCATCACTGA 900 ACAGTGCCCATAGCCATTGTCCAGGA 6
rv: CAATGGAGCCTCTGGTTTGTC 50
IL-1b NM_000576 fw: CTTTGAAGCTGATGGCCCTAAA 300 TCCAGGACCTGGACCTCTGCCCTCT 5
rv: AGTGGTGGTCGGAGATTCGTA 900
IL-6 NM_000600 fw: TGACAAACAAATTCGGTACATCCT 50 CAGCCCTGAGAAAGGAGACATGTAACAA 5.5
rv: TCTGCCAGTGCCTCTTTGCT 900
LIF NM_002309 fw: TGAACCAGATCAGGAGCCAACT 300 CAATGGCAGTGCCAATGCCCTCTTTATT 6
rv: CCACATAGCTTGTCCAGGTTGTT 300
SOX9 Z46629 fw: ACACACAGCTCACTCGACCTTG 900 TTAGGATCATCTCGGCCATCGTCGC 7
rv: GGAATTCTGGTTGGTCCTCTCTT 50
SOX5 NM_006940 fw: CAACCTTGGTGCTGCTGTATCT 300 CACAAACAGCCCACCACCCAAAAGC 6
rv: ATCAGAGGTCTTGGGTTTAGCTGAT 900
SOX6 NM_033326 fw: TGAGGAGCTACCAACACTTGTCA 900 CCATTCAACAAGATGCTGACTGGGACAG 6.5
rv: TCGGAAGGAATATAGGGAACATAACT 900
TNFa NM_000594 fw: CCCCAGGGACCTCTCTCTA 50 AGTCAGATCATCTTCTCGAACCCCGAGTG 6
rv: GGTTTGCTACAACATGGGCTACA 900Six hundred nanograms of either mixed Cy-dye labeled
cRNA or puriﬁed cDNA sample was hybridized for 16 h on
a SensiChip microarray (Qiagen, Zeptosens). Hybridization
was repeated with inversely labeled material generated by
exchanging Alexa- and Cy5-labeled dUTP nucleotides for
IL-1b-treated and control sample. Inverse labeling was
performed to compensate for differential labeling efﬁciency
and ﬂuorescence intensity associated with the two dyes.
After washing steps following the manufacturer’s stan-
dard protocol, arrays were scanned by the SensiChip
Reader. The resulting array images were analyzed using
the SensiChip View 2.1 software (Qiagen, Zeptosens) to
quantify gene-speciﬁc signal intensities.
EXPRESSION DATA ANALYSIS
All microarray scans were inspected visually and
checked for quality based on the performance of negative,
housekeeping and externally added Cy3/Cy5-prelabeled
spiking controls. Raw signal intensities from each scan
were imported into the gene expression analysis software
Resolver version 4.0 (Rosetta Biosoftware, Seattle, USA).
The software employs an error modeling approach for
analysis of microarray data14. An error model speciﬁc for
the SensiChip microarray platform was designed by
Rosetta Biosoftware to determine the variance of signal
intensities, based on expression data from repeated
hybridizations of the same RNA material. The complete
description of the used statistical methods is available in the
technology section of the Rosetta Biosoftware website
(http://www.rosettabio.com/tech/default.htm).
All scans were pre-processed and normalized using the
SensiChip error model to calculate P-values and error barsfor every gene expression proﬁle. The P-value for a gene
estimates the probability that the observed differential gene
expression was due to a measurement error. Gene regula-
tion was considered as statistically signiﬁcant if the cal-
culated P-value was below a threshold of 0.05. For
normalization of expression data, the average brightness
of the Cy3 and Cy5 channels was used, calculated from
spots within a range from 30% to 85% of the signal intensity
distribution of all spots. Scans from multiple experiments
(replicates) were combined by averaging expression data
using an error-weighted algorithm (also described in the
statistical methods document available on the above-
mentioned website).
BIOINFORMATICS ANALYSIS OF TRANSCRIPTION
FACTORS (TFs)
In order to analyze TF activity from the expression data,
groups of potentially regulated target genes were de-
termined for each TF. The required knowledge on TFs
and their target genes are partially contained in databases
like TRANSFAC15 and the scientiﬁc literature. In this study,
a combination of three types of evidence for the regulation
of a target gene by the binding of a TF to its promoter was
used: predicted binding sites, known binding sites, and co-
occurrences of TFs and target genes extracted from the
scientiﬁc literature. Binding site predictions for target genes
were computed with the TRANSFAC tool MATCH on
sequences starting 3 kb upstream from the transcription
start site and ending 1 kb downstream. Known binding
sites were extracted from TRANSFAC’s SITE table15.
Co-occurrences in the literature were computed using the
text-mining tool ProMiner16. A gene was added to the group
of potential target genes of a TF if the gene contained
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both a predicted binding site of TF and a literature co-
occurrence with that TF. Target gene groups were checked
for enrichment of signiﬁcantly regulated genes (P-value!
0.01 for at least one time point) in either cell type. This
enrichment was quantiﬁed by P-values for all the TF target
gene groups using Fisher’s exact test17; the corresponding
‘‘group P-value’’ is the probability of ﬁnding the observed
number of signiﬁcantly regulated genes in the target
gene group by selecting genes randomly. A group P-value
lower than 0.05 was considered signiﬁcant.
ANALYSIS OF MMP-1, -3 AND -13 RELEASE IN IL-1-STIMULATED
SW1353 CHONDROSARCOMA CELLS
5! 104 SW1353 cells/well were seeded into a 96-well
ﬂat-bottom plate in serum-free DMEM medium (Gibco) and
cultured at 37(C and 5% CO2. MMP expression was
induced by stimulation with 0.1 ng/ml IL-1b (Roche) for
24 h. The cell culture supernatant was harvested, centri-
fuged and stored at 20(C until further analysis. Amounts
of MMP-1, -3 and -13 (activated and inactive pro-forms) in
the culture supernatant were determined with commercially
available enzyme linked immunoabsorbent assays from
Amersham Life Science, according to the manufacturer’s
protocol.
Results
SIMILARITIES AND DIFFERENCES IN GENE EXPRESSION
BETWEEN SW1353 AND PHCs
In order to characterize more extensively the SW1353
cell line gene expression proﬁling was performed. PHCs
were analyzed in parallel in order to check for similarities
between the two cell types. Overall, three independent
cultures and stimulation experiments with SW1353 cells
were performed and analyzed separately. Subsequently,
the expression proﬁles were merged bioinformatically. The
PHCs derived from the cartilage of three normal donors
were also cultured independently, but pooled directly after
RNA isolation. The 20 most strongly expressed genes of
both cellular model systems are listed in Table II. All further
data are available as supplementary material (http://
www.bio.iﬁ.lmu.de/publications/SW1353).
In general, most components of the extracellular cartilage
matrix (i.e., anabolic genes) such as collagen types II, III,
and XI, aggrecan, and COMP were hardly detectable in
SW1353 cells in the microarray experiments, whereas they
were well detected in the PHCs (10e100! more than in
SW1353: see supplementary material). This was conﬁrmed
by real-time PCR for collagen type II and aggrecan (data not
shown). Also, although expressed by the SW1353 cells,
ﬁbronectin was considerably reduced compared to PHCs.
Collagen type VI was signiﬁcantly expressed and COL6A3
enhanced compared to PHCs (3.3!). The catabolic genes
were expressed either at considerably reduced levels
(MMP-1: 0.03! and MMP-13: 0.07!) or to a similar or
slightly enhanced extent (MMP-2: 1.4!; ADAMTS-4:
2.6!). Of the cartilage-relevant SOX genes (SOX5,
SOX6, SOX9), all were expressed at very low levels and
signiﬁcantly lower than in PHCs (both in microarray experi-
ments and real-time PCR analysis). Of note, SW1353
expressed no signiﬁcant levels of IL-1b or TNF (tumor
necrosis factor)-alpha (both !0.0001 molecules/molecules
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in
real-time PCR analysis).REACTIVITY OF SW1353 CELLS TO IL-1b
Overall, out of the 312 investigated genes, IL-1b
signiﬁcantly up-regulated 11 genes and signiﬁcantly down-
regulated eight genes (P! 0.05 and 1.2! absolute fold-
change in at least two time points) in SW1353 cells [Table
III(a)].
COMPARISON OF IL-1b REACTIVITY OF SW1353 CELLS
AND PHCs
Overall, IL-1b regulated more genes in PHCs than in the
SW1353 cells (Table III). The different responsiveness of
both cellular systems to IL-1b was also apparent from
comparison of the expression data and dendrograms
resulting from two-dimensional hierarchical clustering of
genes that were signiﬁcantly regulated by IL-1b in SW1353
cells and PHCs, respectively. As shown in Table III and
Fig. 1, the two gene sets overlapped by only a few genes
and resulted in completely different dendrograms. Further-
more, groupings for genes based on the observed
expression data could not be transferred from one system
to the other and were very different if comparing the same
set of genes between the respective systems [Fig. 1(a vs b,
c vs d)].
In order to understand in more detail speciﬁc similarities
and differences between SW1353 cells and PHCs, three
major gene sets were analyzed individually (Table III):
anabolic genes, catabolic genes and intercellular media-
tors.
Among the anabolic genes, not much overlap was found
between the SW1353 cells and the PHCs. After IL-1
treatment, PHCs showed classical down-regulation of
anabolic activity, in particular the expression of collagen
type II (!0.1!; P! 0.001) and aggrecan (0.24!;
P! 0.001). In contrast, no signiﬁcant changes were
observed in the SW1353 cells in the microarray experi-
ments, although very low expression levels were also found
in the non-treated SW1353 cells. Real-time PCR demon-
strated a moderate reduction of collagen type II (down to
50% after 16 h), but not of aggrecan (data not shown). The
only gene signiﬁcantly down-regulated in both SW1353
cells and PHCs was COMP, one of the anabolic genes
expressed at high enough levels in both cell types to allow
accurate quantitation.
In terms of important inducible intercellular mediators we
found basically no expression of IL-1b, IL-6 and LIF in
unstimulated SW1353 cells. After stimulation with IL-1b, we
observed a strong induction of IL-6, but not of LIF, IL-1b
itself or bone morphogenetic protein-2 (BMP-2). All four
mediators were, however, strongly induced in PHCs after
IL-1b stimulation. This was also conﬁrmed by real-time PCR
[Fig. 2(a)]. Again, IL-6 was strongly induced by IL-1b in
SW1353 cells, whereas much less induction was found for
leucemia inhibitory factor (LIF).
Analysis of the catabolic genes showed that SW1353
cells reacted in a broadly similar manner to PHCs. Thus,
genes such as MMP-1, MMP-3, and MMP-13 were all
signiﬁcantly up-regulated by IL-1b, both in SW1353 cells
and PHCs. MMP-2 was expressed (real-time PCR: 0.04/
GAPDH), but not regulated in both SW1353 cells and
PHCs, which is in line with previous results18.
CONFIRMATION OF MMP EXPRESSION AND REGULATION
BY QUANTITATIVE PCR AND ELISA
Quantitative PCR measurements, using RNAs from all
triplicate stimulation experiments performed for the array
701Osteoarthritis and Cartilage Vol. 13, No. 8Table II
Table showing the 20 most strongly expressed genes in SW1353 cells and PHCs. The genes were ranked by the mean of normalized
expression levels (‘‘int’’: intensity). Genes that are listed for both cellular model systems are shown in bold
SW1353 PHC
Gene Accession no. int Gene Accession no. int
ADAM17 NM_021832 16.5 MMP-3 X05232 16.1
TGFB1 NM_000660 12.7 FN1 M10905 15.4
SERPINE1 M16006 11.6 RPL13A X56932 14.7
ADAMTS-4 NM_005099 10.7 SPP1 NM_000582 14.4
TUBA3 AF141347 9.8 TIMP1 X03124 12.2
RPL13A X56932 6.9 FMOD NM_002023 11.0
TIMP1 X03124 4.5 COMP NM_000095 9.7
UBC M26880 3.9 AGC1 NM_001135 9.2
RPS9 U14971 3.6 CHI3L2 NM_004000 7.8
GNB2L1 NM_006098 3.3 ATF4 M86842 7.1
COL6A3 NM_004369 2.9 RPS9 U14971 6.7
ITGA5 NM_002205 2.2 SERPINA1 NM_000295 6.6
CTSB NM_001908 2.2 TGFB1 NM_000660 6.0
MMP-2 J03210 2.2 UBC M26880 5.5
ATF4 M86842 2.0 MMP-1 X05231 4.6
TXN NM_003329 1.9 ADAM17 NM_021832 4.3
SLC25A6 BC007850 1.5 ADAMTS-4 NM_005099 4.0
GPX1 NM_000581 1.5 SERPINE1 M16006 3.6
CTSD NM_001909 1.5 COL6A1 X15880 3.1
COL6A1 X15880 1.4 COL2A1 X16468 2.8studies, conﬁrmed the induction of MMPs-1, -3 and -13 as
major catabolic cartilage enzymes by IL-1b [Fig. 2(b)],
whereas MMP-2 was not induced. Using ELISAs, SW1353
cells (Fig. 3) showed a strong increase in MMP (-1, -3, -13)
secretion after stimulation by IL-1b (MMP-1: 9!; P! 0.05;
MMP-3: 45!; P! 0.005; MMP-13: 33!; P! 0.0001). No
signiﬁcant increase in MMP-2 expression was found (data
not shown), conﬁrming our ﬁndings at the mRNA level.
ANALYSIS OF TFs
Since the activation of TFs can be regulated transcrip-
tionally as well as by protein interaction and modiﬁcation
(e.g., phosphorylation), it is difﬁcult to validate the activity of
a TF by its gene expression level alone. Therefore, we
inferred activation of a TF from its effect on the expression
levels of its potential target gene group.
The analysis of target gene groups showed IL-1b-
mediated induction of ﬁve common target genes by the
TF nuclear factor kappa-B (NFkB) in both cell types. Both
Rel proteins, c-Rel (REL) and RelA (RELA), had signiﬁcant
group P-values below 0.05 for PHCs and for SW1353 cells.
Their predicted group of target genes (represented on the
microarrays) was IL-6, TNF, NFKBIE (NFkB inhibitor
epsilon), intercellular adhesion molecule 1 (ICAM1) and
NFKB1 (Table IV). Figure 4 shows the expression proﬁles
of RelA (c-Rel was not represented on the microarrays) and
the predicted target genes of RelA and c-Rel, which were
similar in the two cell types. The intercellular similarity for
each gene of the NFkB target gene group and RelA was
measured by Pearson correlation coefﬁcients of the log-
ratio expression levels. The overall similarity in the gene
group is higher than that expected by chance. Using the
rank sum test19 to compare the intercellular correlations (of
the ﬁve genes) with all other genes, signiﬁcance at the 5%
level was shown, i.e., the probability of picking ﬁve genes at
random that are similarly correlated between the two
cellular model systems is below 5%. NFKBIE is contained
only in the predicted NFkB gene target group of PHCs cells
but not in the NFkB target group for SW1353 cells. NFKBIEregulation distinguishes the activity of the TF NFkB in the
two cell types. Consistent with this ﬁnding, NFKBIE showed
no correlation of expression levels between the measure-
ments.
For SW1353 cells, two other signiﬁcant TFs were RUNX2
(regulating MMP-13, SMAD 2, MYC, RUNX1 and RUNX2
itself) with a group P-value of 0.05 and RARA (regulating
BGLAP, ICAM1 and MYC) with a group P-value of 0.04. A
second relevant TF for PHCs was ATF2 (regulating
MAPK8, IL-1b, FN1, PLAT and TNF) with a group P-value
of 0.02. Figure 5 shows the expression proﬁles of the
predicted ATF2 target genes. Except for IL-1b, we did not
observe any correlations between the two cell types. In fact,
ATF2, PLAT and FN1 were anti-correlated, conﬁrming the
different roles of ATF2 in the two cell lines.
Discussion
One highly relevant result of our study is that relative to
PHCs, the SW1353 cell line shows much reduced
expression levels of anabolic genes of chondrocytes, i.e.,
constituents of the extracellular cartilage matrix. The only
exception was collagen type VI and to some extent
ﬁbronectin, both constituents of the pericellular matrix.
Whether this reﬂects that chondrocytic cells try primarily to
build up the pericellular matrix, or whether it is chondrocyte-
unrelated is unclear, but a similar feature has previously
been observed in other chondrocytic cell lines2. Although
high absolute expression levels of molecules of interest are
not a prerequisite for successful studies (as discussed
below), it does appear that SW1353 cells are not a priori
a very good candidate in vitro system for studying
chondrocyte anabolism. This is further supported by the
fact that major TFs relevant for the expression of collagen
type II, such as SOX9, SOX5, and SOX6, are hardly
expressed by SW1353 cells compared to PHCs5,20 (own
unpublished results). The notion that SW1353 cells exhibit
only a limited chondrocytic phenotype is in line with
previous reports showing an epithelial phenotype of
SW1353 cells after long-term culture5. Similar to others
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Genes which are significantly regulated (P! 0.05 and 1.2! absolute fold-change in at least two time points) by stimulation with 1 ng/ml IL-1b
in SW1353 cells (a) and PHCs in vitro (b; the values for MMP-3 were beyond the linear range of the measurement and were, therefore, not
included in b). Given are the ratios IL-1b-stimulated vs controls. Genes that are listed for both cellular model systems are shown in bold. (R:
ratio; ns: not significant)
Gene Accession no. 30 min 6 h 16 h 24 h 48 h
R P-value R P-value R P-value R P-value R P-value
(a)
MMP-3 X05232 0.92 ns 26 !0.001 100 !0.001 100 !0.001 96 !0.001
MMP-1 X05231 0.91 ns 6 !0.001 32 !0.001 33 !0.001 18 !0.001
MMP-13 X75308 1 ns 3.1 !0.001 38 !0.001 45 !0.001 10 !0.001
TNFAIP6 NM_007115 1.4 ns 4 !0.001 7.5 !0.001 8.9 !0.001 4 !0.001
HLA-B M81798 0.92 ns 1.7 !0.001 2.6 0.004 2.9 !0.001 2.7 !0.001
IL-6 NM_000600 1.4 ns 28 !0.001 72 !0.001 13 !0.001 2.5 !0.001
CHI3L2 NM_004000 0.74 0.031 1 ns 2.3 0.006 1.5 0.019 1.9 !0.001
MADH1 NM_005900 1.2 0.054 2 !0.001 1.7 0.078 1.7 !0.001 1.6 !0.001
MRS3/4 AF327402 1 ns 5.7 !0.001 2 0.045 1.8 !0.001 1.4 0.05
NFKB1 M58603 1 ns 2.9 !0.001 1.8 0.055 1.8 !0.001 1.2 ns
PPARG NM_138712 0.93 ns 0.69 0.027 0.66 ns 0.67 0.036 0.89 ns
RELA Q04206 1.03 ns 1.92 !0.001 1.05 ns 1.03 ns 0.84 0.003
MADH3 NM_005902 0.89 ns 1.4 !0.001 0.59 ns 0.83 !0.001 0.74 !0.001
ATF2 NM_001880 1 ns 0.86 ns 0.84 ns 0.7 0.001 0.72 !0.001
DLX5 NM_005221 0.8 ns 0.75 ns 1 ns 0.71 0.003 0.63 !0.001
BMP4 NM_001202 0.9 ns 0.8 0.041 0.18 !0.001 0.52 0.001 0.62 !0.001
CAT NM_001752 0.56 0.08 0.51 0.084 0.04 0.013 0.42 0.013 0.6 0.015
Link protein NM_001884 0.64 ns 0.67 ns 0.16 ns 0.28 !0.001 0.35 !0.001
PRKDC NM_006904 1 ns 0.86 ns 0.04 0.032 0.42 0.029 0.32 !0.001
(b)
LIF NM_002309 1.5 ns 24 !0.001 23 !0.001 8.1 !0.001 30 !0.001
TNFAIP6 NM_007115 1 ns 4.9 !0.001 9.2 !0.001 6.4 !0.001 11 !0.001
IL-6 NM_000600 2 0.018 2.8 !0.001 11 !0.001 13 !0.001 11 !0.001
IL-1B K02770 1.3 ns 5.9 !0.001 17 !0.001 20 !0.001 9.4 !0.001
DUSP6 BC003143 1.2 ns 4 !0.001 6.8 !0.001 5 !0.001 7.6 !0.001
MMP-13 X75308 0.91 ns 4.6 !0.001 13 !0.001 11 !0.001 6.8 !0.001
MMP-1 X05231 0.93 ns 3.3 !0.001 4.1 !0.001 3.1 !0.001 5.2 !0.001
NOS2A AB022318 1.1 ns 11 !0.001 9 !0.001 7.1 !0.001 4.9 !0.001
IL-1A X02851 1.3 ns 2.6 0.002 6.7 !0.001 4.8 !0.001 4.6 !0.001
JUN J04111 2.7 !0.001 2.1 0.008 3.7 !0.001 2.7 !0.001 4 !0.001
BMP-2 NM_001200 1 ns 3.16 !0.001 6.6 !0.001 1 ns 4 !0.001
RUNX1 NM_001754 1.1 ns 1.5 ns 3.5 !0.001 3.3 !0.001 3.7 !0.001
NFKBIE U91616 1 ns 2 0.016 2.9 !0.001 2 0.012 2.9 !0.001
NFKB1 M58603 0.86 ns 8.1 !0.001 3 !0.001 2.3 0.004 2.8 !0.001
CD44 NM_000610 1 ns 2.17 0.006 3.3 !0.001 1.9 0.019 2.6 !0.001
TXNRD1 NM_003330 1.1 ns 4.6 !0.001 2.5 0.001 2.4 0.002 2.4 0.002
RELA Q04206 1.5 ns 2 0.018 1.5 ns 2.3 0.004 1.4 ns
FOS V01512 2.4 0.002 0.55 0.07 0.5 0.028 0.55 0.042 0.76 ns
PTHR1 NM_000316 0.87 ns 0.38 0.002 0.5 0.008 0.43 0.003 0.55 0.036
HF1 NM_000186 0.79 ns 0.46 0.006 0.48 0.009 0.42 0.002 0.51 0.018
SPP1 NM_000582 0.49 0.011 0.51 0.017 0.68 0.17 0.51 0.016 0.37 !0.001
COL1A2 X55525 0.79 ns 0.35 !0.001 0.43 0.002 0.4 0.001 0.31 !0.001
COMP NM_000095 0.55 0.032 0.31 !0.001 0.31 !0.001 0.36 !0.001 0.31 !0.001
FGFR2 NM_023028 0.86 ns 0.16 !0.001 0.26 !0.001 0.42 0.002 0.3 !0.001
SCIN NM_033128 1.2 ns 0.49 0.024 0.31 !0.001 0.3 !0.001 0.29 !0.001
COL10A1 NM_000493 0.6 0.068 0.15 !0.001 0.14 !0.001 0.09 !0.001 0.26 !0.001
A2M M11313 0.91 ns 0.48 !0.001 0.35 !0.001 0.33 !0.001 0.23 !0.001
Link protein NM_001884 1 ns 0.59 0.063 0.34 !0.001 0.29 !0.001 0.21 !0.001
GDF5 NM_000557 1 ns 0.4 0.001 0.26 !0.001 0.48 0.009 0.2 !0.001
MATN2 NM_002380 1.2 ns 0.39 !0.001 0.27 !0.001 0.19 !0.001 0.18 !0.001
GDF10 NM_004962 1 ns 0.17 !0.001 0.08 !0.001 0.09 !0.001 0.13 !0.001
MATN3 NM_002381 1.3 ns 0.55 0.033 0.21 !0.001 0.14 !0.001 0.11 !0.001
CKTSF1B1 NM_013372 0.83 ns 0.4 0.001 0.11 !0.001 0.06 !0.001 0.07 !0.001
COL2A1 X16468 0.9 ns 0.31 !0.001 0.11 !0.001 0.09 !0.001 0.06 !0.001we found that despite the low expression levels there was
some indication of down-regulation of collagen type II after
treatment with IL-1b5. This is interesting as it documents
that basic aspects of gene regulation are at least in part also
active in cells in which the genes of interest are minimallyexpressed. In this respect, other chondrocytic cell lines
such as immortalized human chondrocyte cell lines21 are
suitable in vitro systems, despite the lack of signiﬁcant
expression levels of many cartilage-speciﬁc gene prod-
ucts22. Overall, however, one needs to check carefully for
703Osteoarthritis and Cartilage Vol. 13, No. 8Fig. 1. Two-dimensional hierarchical clustering of hybridization experiments from human SW1353 cells and PHCs stimulated in triplicate
with 1 ng/ml IL-1b at 30 min, 6 h, 16 h, 24 h and 48 h. For the ﬁve time intervals of IL-1b stimulation, expression proﬁles of treated samples
were compared to control samples (triplicates each). Dendrograms illustrate SW1353 expression values (a) and PHCs expression values (b)
with genes that were signiﬁcantly regulated by IL-1b in SW1353 cells (1.2! absolute fold-change and P-value! 0.05 in at least two time
points). Dendrograms (c) and (d) show the corresponding expression data for genes that were signiﬁcantly regulated by IL-1b in PHCs (same
criteria as above).
704 M. Gebauer et al.: Molecular phenotyping of SW1353 cellsreactivity in these circumstances and in fact in this study
aggrecan expression in SW1353 cells was not inﬂuenced at
all by IL-1b.
mRNA expression levels of matrix-degrading enzymes
were also partly lower in SW1353 cells than those observed


















control IL-1ß control IL-1ß
MMP-1 0.0006 0.03 0.36 2.7
MMP-3 0.0030 0.31 42.2 111.1
MMP-13 0.0015 0.45 0.07 0.24
/GAPDH
PHCs
control IL-1ß control IL-1ß
IL-6 0.00009 0.066 0.05 2.8
LIF 0.00013 0.0004 0.003 0.06
SW1353
SW1353
Fig. 2. Real-time PCR analysis of the IL-1b induced expression of
IL-6 and LIF (a) and MMP-1, -3, and -13 (b) in SW1353 cells (solid
bars) and PHCs (open bars) after 48 h of stimulation with 1 ng IL-1b
(SW1353: three independent experiments; PHCs: six independent
experiments).MMPs detected in our study are in line with previous work in
which the expression and regulation pattern of especially
MMP-1 and MMP-13 in SW1353 cells was investigated7e10.
In terms of reactivity of MMP expression to IL-1b
stimulation, we found in SW1353 cells a pattern already
known from PHCs in vitro: strong induction of MMP-
19,12,23e25, MMP-312 and MMP-139,12,23,26,27 and no signif-
icant inﬂuence on the expression of MMP-218. This
highlights the merits of studying these phenomena in this
cell type7e10. The same is true for induction of IL-628-32.
However, not all genes reacted in a similar way in SW1353
cells as in PHCs. For example, LIF was hardly induced and
BMP-2 was not found to be up-regulated by IL-1b as would
be expected33,34. Again, in the context of investigating the
regulation of catabolic events one also needs to ensure that
the cell line model adequately mimics the regulation pattern
within the physiological cell type of interest. Activation of
MMP expression by IL-1b is potentially a general effect































































p < 0.0001 
Fig. 3. Representation of protease levels (a: MMP-1; b: MMP-3; c:
MMP-13) secreted into the culture medium by SW1353 cells
without and with stimulation by 0.1 ng/ml IL-1b (for 24 h). Total
protease levels (i.e., active and pro-forms) were measured by the
ELISA (given as ng/ml medium).
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Predicted targets of RelA and c-Rel, the evidence used for the prediction and supporting literature references that were found by browsing











RelA IL-6 C C 39,40
ICAM1 C C 39
NFKB1 C C e
TNF C C 41
c-Rel IL-6 C C 42
ICAM1 C C 43
NFKB1 C C e
NFKBIE C C euse of SW1353 cells as a substitute for chondrocytes is
challenged once more and requires additional experimental
evidence and validation. The selection of chondrocytes
taken for the study might obviously also inﬂuence gene
expression levels. Different donor ages or joints, different
donor sites (e.g., femoral vs tibial) can potentially inﬂuence
gene expression patterns. Overall, variability between
individuals is a major problem in primary cultures per se.
Primary cells may change their phenotypes dramatically in
culture. Thus, 48 h give only limited insight in what these
cell do. In fact it is possible that they become more similar to
SW1353 cells after prolonged culture. In particular after
losing their differentiated phenotype they certainly lose
chondrocyte-typical gene expression35,36.
A study similar to ours was performed previously37, but
with only one early data point measured after stimulation
with IL-1b (2 h). This study concentrated on early response
genes, namely TFs, which are regulated at this early stageand which were not within the focus of our investigation. In
a very recent study paralleling some aspects of ours,
comparable results were found after IL-1b stimulation,
although the cells were much less responsive to TNF-
alpha38. In this study, however, neither phenotypic charac-
terization of the cell line nor bioinformatics analysis of the
relevant intracellular gene regulatory pathways was per-
formed.
Our bioinformatics analysis identiﬁed relevant regulation
contexts, one of which was regulation through the TF NFkB
(c-Rel, RelA), in which the similarity of the expression of the
predicted target genes between the two cell types was
signiﬁcant (correlation P-value! 0.05). All other predicted
regulation contexts were relevant for only one cell type, but
not for both (e.g., TFs ATF2 for PHCs, and RUNX2 and
RARA for SW1353 cells). However, even in the predicted
regulation context for NFkB, expression data between the
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Fig. 4. Expression proﬁles of genes in the predicted NFkB regulation context (the only regulation context common to both systems according
to our analysis) as log-ratios of expression levels between IL-1b stimulated cells and untreated cells against time in hours after the treatment.
Proﬁles for SW1353 cells are shown as dashed lines, proﬁles for PHCs as solid lines. Correlation values quantify the similarity between the
two systems for each gene. Statistical analysis showed that the correlation of the NFkB targets is signiﬁcantly higher than expected by chance
(details are given in the text).
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Fig. 5. Expression proﬁles of genes in the predicted ATF2 regulation context as log-ratios of expression levels between IL-1b stimulated cells
and untreated cells against time in hours after the treatment. Proﬁles for SW1353 cells are shown as dotted lines, proﬁles for PHCs as drawn
lines. Correlation values quantify the similarity between the two systems for each gene. Statistical analysis showed that the correlation of the
ATF2 targets is not signiﬁcant (details are given in the text). (*The down-regulation of TNF-alpha after 16 h in PHCs might represent
a calculation error due to very low expression levels detected.)for NFKBIE. Reasons for the observed differences could be
due to different activation or abundance of the NFkB sub-
units, or additional relevant TFs in the respective cell types.
Taken together, our data characterize SW1353 cells as
a cell line with only a limited potential to mimic PHCs, since
SW1353 cells barely express typical marker genes of
chondrocytic differentiation. In addition, the overlap in similar
gene expression for the 312 genes measured on the
SensiChip was quite small, indicating that conclusions
drawn based on measurements with the SW1353 cell line
cannot be used as general predictions for the behavior of
PHCs. Despite this, SW1353 cells appear to be a valuable
in vitro system for investigating catabolic gene regulation by
IL-1b (and presumably also TNF-alpha10 and FGFs (ﬁbro-
blast growth factor)5) in chondrocytic cells. In addition, our
bioinformatic study of more general signaling mechanisms
indicates that the involvement of important TFs such as
NFkB can be predicted correctly. This implies that with
appropriate methods some predictions from the SW1353
data can be made for the mechanisms in PHCs, despite the
fact that the actual quantitative expression data within the
two systems are quite diverse. Further studies have to prove
or disprove the further potential of the SW1353 cell line,
which in terms of culturing properties is a very suitable in vitro
model system.
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